Minghao Guo

480 total citations
21 papers, 351 citations indexed

About

Minghao Guo is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minghao Guo has authored 21 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Nephrology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minghao Guo's work include Chronic Kidney Disease and Diabetes (4 papers), Spondyloarthritis Studies and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Minghao Guo is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Spondyloarthritis Studies and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Minghao Guo collaborates with scholars based in China, United States and Australia. Minghao Guo's co-authors include Qingsong Huang, Qi Cao, Jing Tan, Vincent Lee, Zhiguo Niu, Lu Zhang, Dandan Sun, Yan Bao, Yan Cui and Haijun Ma and has published in prestigious journals such as The FASEB Journal, Journal of the American Society of Nephrology and Behavioural Brain Research.

In The Last Decade

Minghao Guo

18 papers receiving 350 citations

Peers

Minghao Guo

IMMUN

SURGE

NEPHR

PRM

A Papayianni United States

Holly Hutton Australia

Roser Guiteras Spain

Yoshiko Mizushina Japan

Chenxuan Yang China

Jingjing Cao China

Lingwei Jin China

Lydie Noé France

Maili Zimmermann Netherlands

Maocai Luo China

A Papayianni United States

Minghao Guo

232 ×1.3

IMMUN

98 ×1.0

68 ×0.8

SURGE

122 ×1.8

NEPHR

73 ×1.8

PRM

Citations per year, relative to Minghao Guo Minghao Guo (= 1×) peers A Papayianni

Countries citing papers authored by Minghao Guo

Since Specialization

Citations

This map shows the geographic impact of Minghao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghao Guo more than expected).

Fields of papers citing papers by Minghao Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghao Guo. The network helps show where Minghao Guo may publish in the future.

Co-authorship network of co-authors of Minghao Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Minghao Guo. A scholar is included among the top collaborators of Minghao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghao Guo. Minghao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Minghao, Henry Chen, Yipeng Huang, et al.. (2025). Genesis: A Compiler for Hamiltonian Simulation on Hybrid CV-DV Quantum Computers. 1583–1597.

Gao, Hongjun, et al.. (2024). Coordinated Generation Scheduling Considering Peak Regulation Cost Allocation and Compensation Distribution in Power Systems. Journal of Modern Power Systems and Clean Energy. 13(6). 1921–1932.

Jin, Li, et al.. (2024). Comparison of the efficacy of steroid-free versus classic steroid-containing regimens in primary membranous nephropathy. Frontiers in Pharmacology. 15. 1286422–1286422. 1 indexed citations

Zhang, Jingtao, et al.. (2023). Ze-Qi decoction inhibits non-small cell lung cancer growth and metastasis by modulating the PI3K/Akt/p53 signaling pathway. Journal of Traditional and Complementary Medicine. 13(5). 417–429. 4 indexed citations

Zhang, Jingtao, Haitao Li, Minghao Guo, et al.. (2023). FHL1 As a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung Adenocarcinoma. Immunotherapy. 15(4). 235–252. 5 indexed citations

Gan, Liangying, Lei Xing, Linghui Zhou, et al.. (2023). Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial. Clinical Kidney Journal. 17(1). 3 indexed citations

Xu, Fei, Lingyun Ji, Wenqiang Cui, et al.. (2023). Inhibition of Non-small Cell Lung Cancer by Ferroptosis and Apoptosis Induction through P53 and GSK-3β/Nrf2 Signal Pathways using Qingrehuoxue Formula. Journal of Cancer. 14(3). 336–349. 17 indexed citations

Jia, Xinyan, et al.. (2022). Diabetic nephropathy with primary membranous nephropathy: A case report. 2(3). 52–55.

Chen, Ai, Hongwang Cui, Tian Su, et al.. (2022). Renal tubular epithelial cell necroptosis promotes tubulointerstitial fibrosis in patients with chronic kidney disease. The FASEB Journal. 36(12). e22625–e22625. 20 indexed citations

10.

Zhang, Jingtao, Dongli Wang, Xiubao Chen, et al.. (2022). Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma. Frontiers in Genetics. 13. 825685–825685. 5 indexed citations

11.

Li, Yao, Xuemin Xu, Chunyan Li, et al.. (2021). OGDHL ameliorates cognitive impairment and Alzheimer's disease-like pathology via activating Wnt/β-catenin signaling in Alzheimer's disease mice. Behavioural Brain Research. 418. 113673–113673. 7 indexed citations

12.

Ma, Haijun, Chang Liu, Bingyu Shi, et al.. (2018). Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis. EBioMedicine. 32. 21–30. 28 indexed citations

13.

Cao, Qi, Yiping Wang, Zhiguo Niu, et al.. (2018). Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology. 29(3). 961–976. 104 indexed citations

14.

Liu, Yun, et al.. (2017). Polymorphisms of human leukocyte antigen B*27 on clinical phenotype of spondyloarthritis in Chinese. Journal of Clinical Laboratory Analysis. 32(2). 1 indexed citations

15.

Ma, Haijun, et al.. (2017). TNF-α-308 polymorphism determines clinical manifestations and therapeutic response of ankylosing spondylitis in Han Chinese. Medicina Clínica (English Edition). 149(12). 517–522. 2 indexed citations

16.

Zhang, Lu, et al.. (2017). Nerolidol Protects Against LPS-induced Acute Kidney Injury via Inhibiting TLR4/NF-κB Signaling. Phytotherapy Research. 31(3). 459–465. 55 indexed citations

17.

Huang, Qingsong, Zhiguo Niu, Jing Tan, et al.. (2015). IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury. Journal of the American Society of Nephrology. 26(9). 2199–2211. 74 indexed citations

18.

Wang, Yongtao, Chenyan Zhou, Jun Yang, et al.. (2013). Analysis of Kidney Biopsy Data From a Single Center in the Midland Rural Area of China, 1996–2010. Current Therapeutic Research. 74. 22–25. 8 indexed citations

19.

Guo, Minghao, et al.. (2011). Different clinical features in patients with ankylosing spondylitis from southern and northern China. International Journal of Rheumatic Diseases. 15(2). 154–162. 10 indexed citations

20.

Guo, Minghao. (2009). Expression of OPN and CD44 in rat kidney with unilateral ureteral obstruction. China Medical Herald. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact